Literature DB >> 10573060

Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B.

J I Lee1, R W Ganster, D A Geller, G J Burckart, A W Thomson, L Lu.   

Abstract

BACKGROUND: The maturation of dendritic cells (DC) is influenced by various factors, in particular cytokine-mediated signaling events. These include modulation of the activation of nuclear factor kappa B (NF-kappaB), which controls the transcription of genes encoding major histocompatibility complex (MHC) antigens, and costimulatory/accessory molecules for T-cell activation. Here, we investigated the influence of cyclosporine A (CsA) on the in vitro maturation of DC, and on the nuclear translocation and DNA binding of NF-kappaB.
METHODS: DC progenitors were propagated from mouse bone marrow in granulocyte-macrophage colony-stimulating factor (GM-CSF) or in GM-CSF plus either transforming growth factor (TGF)-beta or interleukin (IL)-4, in the presence or absence of CsA (1 microg/ml). After 5 days of culture, cell surface expression of MHC class I/II, CD40, CD80, and CD86 was analyzed by flow cytometry, and nuclear NF-kappaB proteins by electrophoretic mobility shift, antibody supershift, and Western blot assays. The antigen-presenting function of DC was determined in one-way mixed leukocyte reactions.
RESULTS: Exposure of replicating DC progenitors propagated in GM-CSF or GM-CSF+TGF-beta to CsA reduced costimulatory molecule expression, without affecting MHC antigen expression. Nuclear extracts from the CsA-treated DC revealed a decrease in nuclear translocation of NF-kappaB (p50). Mixed leukocyte reaction data were consistent with the flow cytometry and gel shift assay results, and showed reduced allostimulatory ability of the CsA-treated cells compared with untreated controls. Addition of IL-4 from the start of DC cultures conferred resistance to CsA-induced inhibition of NF-kappaB nuclear translocation and DC maturation.
CONCLUSIONS: CsA differentially inhibits the expression of key cell surface costimulatory molecules by in vitro-generated DC. This effect can be overcome, at least in part, by IL-4 and augmented by TGF-beta. The inhibition is linked to a decrease in nuclear translocation/DNA binding of NF-kappaB. Thus, CsA can alter the antigen-presenting function of DC for T-cell activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573060     DOI: 10.1097/00007890-199911150-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  21 in total

1.  Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets.

Authors:  Kenichirou Tajima; Ryuichi Amakawa; Tomoki Ito; Michihiko Miyaji; Masashi Takebayashi; Shirou Fukuhara
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

2.  Calcineurin-mediated Bad translocation regulates cyanide-induced neuronal apoptosis.

Authors:  Yan Shou; Li Li; Krishnan Prabhakaran; Joseph L Borowitz; Gary E Isom
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

3.  Frequent calcium oscillations lead to NFAT activation in human immature dendritic cells.

Authors:  Mirko Vukcevic; Francesco Zorzato; Giulio Spagnoli; Susan Treves
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

Review 4.  Tolerogenic dendritic cells and their potential applications.

Authors:  Jim Hu; Yonghong Wan
Journal:  Immunology       Date:  2011-01-05       Impact factor: 7.397

5.  Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo.

Authors:  N M Rogers; S Kireta; P T H Coates
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

6.  Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells.

Authors:  D Rojas-Canales; R Krishnan; C F Jessup; P T Coates
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

7.  IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells.

Authors:  Heth R Turnquist; Tina L Sumpter; Allan Tsung; Alan F Zahorchak; Atsunori Nakao; Gerard J Nau; Foo Y Liew; David A Geller; Angus W Thomson
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  Combined cyclosporin-A /prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells.

Authors:  M A Frassanito; R Dammacco; T Fusaro; A Cusmai; S Guerriero; C Sborgia
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

9.  Macrophage activation syndrome in juvenile rheumatoid arthritis successfully treated with cyclosporine A: a case report.

Authors:  Chan-Ran You; Hae-Rim Kim; Chong-Hyeon Yoon; Sang-Heon Lee; Sung-Hwan Park; Ho-Youn Kim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

10.  Adult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A.

Authors:  Jae-Hong Park; Joong Ho Bae; Yeon-Soo Choi; Hye-Soon Lee; Jae-Bum Jun; Sungsoo Jung; Dae-Hyun Yoo; Sang-Cheol Bae; Tae-Hwan Kim
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.